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Summary 
Direct and indirect cytopathic mechanisms have been 
proposed to account for the loss of CD4+ T cells after 
infection with human immunodeficiency virus type 1 
(HIV-l). We report here that HIV-1 infection of the hu- 
man thymus in vivo results in thymocyte depletion by 
at least two different mechanisms. Thymocytes within 
multiple stages of differentiation are induced to die of 
apoptosis; most of these cells are uninfected. Addi- 
tionally, thymopoiesis is interrupted by direct infec- 
tion and destruction of intrathymic CD3-CD4+CD8- 
progenitor cells. These mechanisms are differentially 
induced by distinct isolates of HIV-l. 
Introduction 
The human immunodeficiency lentivirus HIV-1 is the etio- 
logic agent of the acquired immunodeficiency syndrome 
(AIDS). Studies of HIV-l replication have led to an appreci- 
ation of complex and novel programs for gene expression 
and regulation (for reviews see Cullen, 1991; Feinberg and 
Greene, 1992; Vaishnav and Wong-Staal, 1991). Compar- 
atively little progress has been made, however, in under- 
standing the pathogenic mechanisms of HIV-1 disease in 
infected humans (for reviews see Duesberg, 1994; Fauci, 
1993; Fields, 1994; Levy, 1993; McCune, 1991; Weiss, 
1993). 
The decline of CD4’ T cells in the peripheral circulation 
has been considered an indicative barometer of HIV-1 dis- 
ease progression (Fauci, 1988; Gottlieb et al., 1981; 
Weiss, 1993). A variety of mechanisms have been pro- 
posed to account for this loss of CD4+ T cells. HIV-1 may 
bind to CD4’target cells (Dalgleish et al., 1984; Klatzmann 
et al., 1984) and kill them directly (Cheng et al., 1988; 
Greene, 1993; Terai et al., 1991; Tersmette et al., 1989) 
or subsequent to formation of multinucleated syncytiawith 
uninfected CD4+ bystander cells (Lifson et al., 1988; So- 
droski et al., 1988). Alternatively, uninfected CD4+ cells 
may be eliminated by indirect effects, e.g., interactions 
with viral proteins (Banda et al., 1992; Finkel and Banda, 
1994; Gougeon et al., 1993; Viscidi et al., 1989), alter- 
ations in physiologic cytokine networks (Clerici et al., 
1993), or immunologic reactions of an autoimmune nature 
(Ascher and Sheppard, 1988; Lyerly et al., 1987; Siliciano 
et al., 1988; Stricker et al., 1987; Zinkernagel and Hengart- 
ner, 1994). 
Whether the initiating signal is direct or indirect, morpho- 
logic and biochemical correlatesof programmed cell death 
(or apoptosis) have been associated with HIV-l-induced 
cell death in vitro (Ameisen and Capron, 1991; Laurent 
et al., 1991; Terai et al., 1991; Finkel and Banda, 1994). 
Peripheral T cells isolated from seropositive individuals 
can be induced to undergo apoptosis when they are acti- 
vated in tissue culture (Groux et al., 1992; Meyaard et al., 
1992) or when they are exposed to HIV-1 -encoded gpl20 
followed by activation through the T cell receptor (Banda 
et al., 1992). It is possible that similar activation events 
occur in vivo and that HIV-1 -associated imbalances of cy- 
tokine production or in the generation of autoreactive cyto- 
lytic T lymphocytes may also play a role in inducing 
apoptosis. There is little direct evidence, however, that 
HIV-1 infection induces apoptosis in vivo, and no relation- 
ship has been established between disease progression 
and the ability to induce apoptosis in patient T cells after 
activation in vitro (Meyaard et al., 1994). 
The pathophysiologic correlates leading to T cell deple- 
tion may be better discerned by direct evaluation of inter- 
actions between the virus and defined hematolymphoid 
microenvironments in vivo (McCune et al., 1991; McCune, 
1991). Thus, the bone marrow harbors a constellation of 
CD4+ hematopoietic cells at varying stages of differentia- 
tion, including matureTcells, mature myeloid cells (mono- 
cytes and macrophages), and hematopoietic progenitor 
cells (Chervenak et al., 1993). In this setting, HIV-1 may 
induce apoptosis within progenitor cells, either directly 
after infection or indirectly after perturbation of other stro- 
mal or accessory cells that maintain their function. Consis- 
tent with this possibility is the observation that HIV-l-infected 
individuals often develop anemia, thrombocytopenia, leu- 
kopenia, and bone marrow dysplasia (Calenda and Cher- 
mann, 1992; Castella et al., 1985; Spivak et al., 1983). At 
later stages of hematopoietic differentiation, the thymus 
and peripheral lymphoid organs (such as lymph nodes, 
spleen, and mucosal-associated lymphoid organs) pro- 
vide cellular microenvironments for CD4+ T cell differen- 
tiation and function. In the thymus, CD4 is present not 
only on mature (CD3+CD4+CD8-) T cells but also on less 
mature (CD3-“%D4+CD8+) thymocytes and intrathymic 
(CD3-CD4+CD8-) progenitor cells (Galy et al., 1993; Kraft 
et al., 1993). Though not well studied during HIV-1 infec- 
tion, the thymus has been implicated as a site of viral 
replication (De Rossi et al., 1990; Dwyer et al., 1987; Harris 
et al., 1991; Schnittman et al., 1990; Schuurman et al., 
1989; Tremblay et al., 1990) and thymic organs from HIV- 
l-infected fetuses and pediatric patients show profound 
parenchymal damage and involution (Grody et al., 1985; 
Joshi and Oleske, 1985; Papiernik et al., 1992; Rosenz- 
weig et al., 1993; Savino et al., 1988; Seemayer et al., 
1984). Such effects may be secondary to destruction of 
mature cells, to interruption of thymopoiesis by destruction 
of intrathymic progenitor cells, or to both. The latter possi- 
bility has been suggested by studies that indicate that 
CD3-CD4-‘%D8- cells are permissive for infection with 
HIV-1 in vitro, but it is unclear from these studies whether 
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the infected cells within this heterogeneous population are 
actually T progenitor cells (Schnittman et al., 1990; Valen- 
tin et al., 1994). Finally, lymph nodes from HIV-l-infected 
patients show active viral replication at various stages of 
disease (Armstrong and Horne, 1984; Biberfeld et al., 
1985; Embretson et al., 1993; Ewing et al., 1985; Pantaleo 
et al., 1993). The sustained presence of a locally concen- 
trated viral load within such a microenvironment may con- 
tribute, directly or indirectly, lo elimination of CD4+ T cells 
(Fauci, 1993). 
Since these organ systems are difficult to study in hu- 
man subjects, we have developed and optimized small 
animal models for the analysis of human hematopoiesis. 
The SCID-hu mouse is constructed by engrafting human 
fetal hematolymphoid organs into the immunodeficient 
C.B-17 scici/scid @CID) mouse stock (Bosma and Carroll, 
1991; McCune et al., 1988). If the engrafted organs main- 
tain normal structure and function, they may then serve 
as a substrate for studies of human physiology and patho- 
physiology. When, for instance, fragments of human fetal 
liver and thymus are coengrafted into SCID mice, the re- 
sulting thymuslliver (Thy/Liv) organ promotes long-term 
human Tcell differentiation in a manner that appears phys- 
iologically normal (Krowka et al., 1991; Namikawa et al., 
1990). Cell subpopulations are represented within the or- 
gan in expected proportions, a normal T cell receptor Vb 
repertoire is displayed (Vandekerckhove et al., 1992), and 
tolerance is induced towards both self-major histocompati- 
bility antigens and exogenously provided superantigens 
(Wailer et al., 1992). Given the apparently normal physiol- 
ogy of the SCID-hu ThylLiv organ, we and others have 
used this model to explore the pathophysiologic mecha- 
nisms of HIV-1 infection in vivo. The organ system has 
been found permissive for infection with HIV-1 (Namikawa 
et al., 1988). The kinetics of infection proceed in a dose- 
and time-dependent manner and are suppressed by in vivo 
administration of nucleoside analogs such as zidovudine 
(AZT) (McCune et al., 1990). After infection of the SCID-hu 
Thy/Liv with HIV-l, thymocyte depletion occurs with an 
inversion of the CD4/CD8 ratio (Aldrovandi et al., 1993; 
Bonyhadi et al., 1993; Stanley et al., 1993). These events 
are accompanied by histologic evidence of apoptosis (Bo- 
nyhadi et al., 1993) and transpire at a more accelerated 
pace with rapidly replicating syncytium-inducing virus iso- 
lates than with slowly replicating nonsyncytium-inducing 
virus isolates (Kaneshima et al., 1994). Finally, and as is 
observed in the SIV-infected rhesus macaque (Kestler et 
al., 1991), replication and pathologic effects (e.g., thy- 
mocyte depletion) of HIV-1 in the SCID-hu mouse occur 
more efficiently with an intact NEF open reading frame 
(Jamieson et al., 1994). 
In this report, we dissect the events of HIV-1 infection 
within the Thy/Liv organ to address two questions: first, 
does HIV-l-mediated T cell death occur by direct or indi- 
rect means within this microenvironment in vivo? Second, 
is thymocyte depletion due, in part, to destruction of intra- 
thymic T progenitor cells? Using multiparameter flow cyto- 
metric analysis and cell sorting coupled with a semiquanti- 
tative polymerase chain reaction (PCR) assay for detection 
of HIV-1 DNA, we find that most of the dying cells within 
the HIV-l-infected Thy/Liv organ are undergoing apop- 
tosis and that most of these are not infected with HIV-l. 
Additionally, we provide definitive evidence that the intra- 
thymic CD3-CD4+CD8- T progenitor cell subpopulation 
constitutes a target for HIV-1 infection in vivo. Some HIV-1 
isolates infect this population and deplete it; others infect 
it and do not lead to its immediate depletion. 
Results 
HIV-1 Infection In Vivo Leads to Human Thymocyte 
Depletion by Induction of Apoptosis 
Previous studies of HIV-l-infected Thy/Liv organs demon- 
strated that thymocyte depletion occurs with morphologic 
evidence of apoptosis (Bonyhadi et al., 1993). Since DNA 
strand breaks within intact cells represent a biochemical 
hallmark of apoptosis, we used flow cytometric detection 
of the transfer of biotinylated dUTP to free 3’-OH ends (by 
terminal deoxynucleotidyl transferase, or TdT) to obtain 
a quantitative estimate of apoptosis within the thymus. 
Pilot experiments demonstrated that this assay detected 
dexamethasone-induced apoptosis within the BALB/c 
mouse thymus, even in cells with normal morphology (by 
forward and side scatter analysis and normal DNAcontent) 
(Figure 1A; data not shown) and before DNA ladders were 
observed on agarose gels (data not shown). 
When SCID-hu Thy/Liv mice were infected with the 
HIV-1 isolate NL4-3 (Adachi et al., 1988), TdT reactivity in 
human thymocytes resembled that observed in the mouse 
thymocytes after dexamethasone treatment (Figure 1 B). 
Thus, 3 weeks after a mock infection, most normal thymo- 
cytes fell within the live cell gate and were TdT-. In con- 
trast, HIV-1 infection resulted in the depletion of most 
CD4+CD8+ thymocytes by this timepoint and, among those 
cells that remained in the live cell gate, 53% were TdT+. 
Kinetic studies were conducted to relate apoptosis (as 
evaluated using the TdT assay) to changes in cellularity 
and composition of the HIV-l-infected Thy/Liv organ (Fig- 
ure 1C). At 2 weeks postinfection (wpi) with NL4-3, when 
there was minimal change in thymocyte composition, 506 
10% of cells were TdT+. At later stages of infection (3-5 
wpi), evidence of severe thymocyte depletion was associ- 
ated with high levels of TdT positivity (40%-80%) in all thy- 
mocyte subpopulations, including CD4+CD8-, CD4-CD8’ 
and CD4+CD8’ cells (Figure 1 D). 
HIV-1 Infection Can Lead to Indirect Killing 
of Human Thymocytes 
A semiquantitative DNA-PCR assay was developed to es- 
timate the fraction of thymocytes directly infected by HIV-l. 
A chronically infected human T cell line (ACH2, with one 
copy of HIV-1 proviral DNA/cell) served as a standard. 
Human thymocytes were mixed with varying percentages 
of ACH2 cells and analyzed by the PCR method (Figure 
2A). Out of 100 cells, 1 ACHP cell (i.e., 1% HIV+) could 
be detected reproducibly, and a semiquantitative increase 
in the PCR signal was observed in the range of l%-10% 
HIV-l-infected cells. 
In thymocytes from HIV-infected SCID-hu Thy/Liv, in- 
creasing levels of HIV-1 DNA were detected as a function 
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Figure 1. Induction of Apoptosis in Human Thymocytes by HIV-1 In- 
fection 
(A) Mouse thymocytes from 4-6 weeks old BALE/c mice treated with 
dexamethasone were used to standardize the TdT-FACS assay. Cells 
with normal morphology by side scatter and forward scatter were gated 
(left) and analyzed for the TdT label (TdT-fluorescein isothiocyanate) 
(right). Minus DEX, normal BALB/c thymocytes; plus DEX, thymocytes 
from BALB/c mice treated with dexamethasone. The percentage of 
TdT+, or apoptotic, cells is indicated. 
(8) Induction Of apoptosis in human thymocytes by HIV-1 infection. 
Human thymocytes with normal morphology (within live cell gate by 
forward and side scatters) were analyzed for DNA strand breaks after 
HIV-1 infection (3 wpi by NL4-3). Mock, thymocytes from uninfected 
SCID-hu ThylLiv; HIV-1 (NL4-3) thymocytes from SCID-hu Thy/Liv 
grafts, 3 weeks after infection with NL4-3 (at this timepoint, most 
CD4+CD8+ cells were depleted). The percentage of TdT+ cells is indi- 
cated. 
(C) Kinetics of apoptosis induction. TdT-FACS was performed with 
human thymocytes isolated from SCID-hu Thy/Liv grafts at different 
timepoints after infection with HIV-I (NL4-3). The number of SCID-hu 
Thy/Liv animals analyzed at each timepoint is indicated in parenthe 
sea SEM are shown. 
(D) HIV-l-induced apoptosis in different human thymocyte subpopula- 
tions. TdT-FACS was performed in combination with FACS analyses 
of CD4 and CD6 markers. NC, thymocytes from a Thy/Liv graft, 4 
weeksafter mock infection; NL(4 wpi), thymocytesfrom aThy/Livgraft, 
4 weeks after infection with NL4-3. Percentages of all three thymocyte 
subpopulations are expressed as a percentage of total live thymocytes. 
CD4’. human thymocytes showing CD4+CD8- staining: CD4+CD8+, 
human thymocytes with surface expression of both CD4 and CDE; 
CDE’, human thymocytes showing CD4CD8’ staining. The percent- 
age of TdT+ cells within each subpopulation is indicated. 
at 3 and 4 wpi. Since each HIV-l-infected cell may have 
carried multiple copies of HIV-1 proviral DNA, these esti- 
mates represent upper limits. 
When the TdT assay was used to quantitate the fraction 
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Figure2. Quantitation of HIV-l Infection in 
SCID-hu Thy/Liv 
(A) Semiquantitative PCR assay to estimate the 
percentage of cells infected with HIV-l within 
a given cell population. The PCR product for 
HIV-l DNA is from the HIV gag region (142 
bp). The human 6-globin gene (266 bp) was 
amplified as a positive control for human cells. 
Left, lanes l-6 are PCR reactions of cell mix- 
tures containing 50%, 25%, lo%, 5%, I%, or 
no ACHP cells. Lane 7 (NC) is a PCR reaction 
with no human DNA template. Right, human 
cell mixtures containing 50%, lo%, or 5% 
ACHP cells were analyzed directly (lanes 1) or 
after dilution with DNA from normal human thy- 
mocytes (10 x , lanes 2; or 100 x , lanes 3). 
(B) Infection of human thymocytesduring HIV-1 
infection. Human thymocytes from SCID-hu 
Thy/Liv infected by HIV-l NL4-3 (top) or EW 
(bottom) were analyzed as a function of time 
(2-4 wpi). Lanes 1, infected samples; lanes 2: 
10x diluted; lanes 3: 100x diluted. Repeated 
experiments (more than three times) gave com- 
parable results. 
of thymocytes undergoing apoptosis, an increasing differ- 
ential was noted between the number of infected cells and 
the number of dying cells (see Figure 1; Figure 2; Table 
1). Thus, at 4-5 wpi with NL4-3, about 500/b-60% of cells 
were TdT+, whereas only 10% of the cells were infected. 
To confirm that the TdT+ (apoptotic) cells were not infected 
with HIV-l, TdT+ and TdT- cells (about 60% of human 
thymocytes were TdT+ at 4 wpi with NL4-3 and 30% were 
TdT+ at 4 wpi with EW) were separated to >95% purity 
by cell sorting and analyzed separately for HIV-1 proviral 
Table 1. HIV Infection and Induction of Apoptosis in Thymic Progenitor Cells 
Percentage of PCR’ (Infected) Cells 
HIV-l wpi 
Percentage Percentage 
of Total of CDbCD4’ 
Percentage 
of CD3+CD4+ 
NC 
NL4-3 
NL4-3 
NL4-3 
NL4-3 
NL4-3 
EW 
EW 
EW 
Percentage of TdT+ (Apoptotic) Cells 
HIV-1 wpi 
0 ND 
1 ND 
10 50 
IO 50 
10 ND 
10 ND 
5 5 
10 10 
10 10 
Percentage Percentage 
of Total of CD3dD4’ 
ND 
ND 
10 
10 
ND 
ND 
5 
25 
25 
Percentage 
of CD3+CD4+ 
NC 0 <2 <2 
NL4-3 1 <2 ND 
NL4-3 2 5 10 
NL4-3 3 30 50 
NL4-3 4 40 ND 
NL4-3 5 60 ND 
EW 2 2 2 
EW 3 7 2 
EW 4 30 30 
ND, not done. 
wpi, weeks post infection. 
Percentage of HIV+ or percentage of TdT+, estimation from two or more experiments. 
<2 
ND 
10 
50 
ND 
ND 
2 
5 
30 
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TdT+ TdT- TdT+ TdT- 50% 10% 9% 
DNA. As shown in Figure 3, only about 10% of the TdT’ 
cells were HIV-1 +, a level of infection also seen in the TdT- 
and unseparated (data not shown) populations. Thus, the 
vast majority of dying cells are uninfected. 
lntrathymic Progenitor Cells Are Target Cells 
for HIV-1 Infection 
Double-positive (CD3-‘+CD4+CD8+) and mature single- 
positive (CD3+CD4+CD8-) thymocytes are derived from in- 
trathymic progenitor cells with a CD3-CD4+CD8- pheno- 
type (Galy et al., 1993; Kraft et al., 1993). It is possible 
that cells from each of these subpopulations may be intra- 
thymic targets for HIV-1 infection. Three-color flow cytom- 
etry was performed to analyze the relative distribution of 
various thymocyte subpopulations as a function of time 
after HIV-1 infection. In concordance with a previous report 
with fresh human fetal thymus (Kraft et al., 1993) the 
progenitor (CD3-CD4+CD8-) cell population represented 
about 17% (SEM = 1.00/o, range = 0.90/o-53%, n = 89 
SCID-hu mice) of CD4+CD8- thymocytes (Figure 4; Figure 
5), the remainder being mature CD3+CD4+CD8- thymo- 
cytes. No significant difference in the percentage of pro- 
genitor cells was noted upon analysis of uninfected or 
mock-infected SCID-hu ThylLiv mice. 
The representation of this progenitor population was dif- 
ferentially affected by infection with the HIV-1 isolates 
NL4-3, EW, and JD. At early timepoints after infection with 
NL4-3 (0.5-l .5 weeks, labeled as 1 wpi in Figure 5A), there 
was fluctuation ranging between 0.0%-270/o in the per- 
Mock HIV (NL4-3) HN 
P-globin 
HIV-gag 
Figure 3. HIV-1 Infection and Apoptosis 
TdT+ cells and TdT- cells from HIV-l-infected 
SCID-hu thymocytes (4 wpi with NL4-3 or EW) 
were purified by TdT-FACS and analyzed by 
PCR to estimate HIV-1 infection as in Figure 
2. DNA samples prepared with cells containing 
known percentages of ACHP cells (50%, lo%, 
and 5%). Lanes 1, undiluted sample DNA; 
lanes 2, 10 x diluted with DNA prepared from 
normal cells; lanes 3, 100x diluted. Each ex- 
periment was repeated at least twice. 
centage of CD3-CD4+CD8- progenitor cells (mean = 10.4, 
SEM = 4.9, n = 28). By two weeks after infection with 
NL4-3, the percentage of CD3CD4’CD8- progenitor cells 
had clearly decreased to a mean percentage of 9.1% 
(SEM = 1.20/o, range = 0%-230/o, n = 49 SCID-hu mice). 
At later stages postinfection, when the CD4+CD8+ popu- 
lation was severely depleted (data not shown), the 
CD3-CD4+CD8- population dropped further to about 5.5% 
at 3 wpi (SEM = 1.20/o, range = 0.9%-10.4%, n = 13) 
4.8% at 4 wpi (SEM = 0.8, range = 0%-610/o, n = 33), 
and 2.2% at 5 wpi (SEM = 1.6%, n = 3) of the total 
CD4+CD8- cells. 
In contrast, infection of SCID-hu Thy/Liv mice with the 
primary isolates EW and JD resulted in preferential elimi- 
nation of mature CD4+ (CD3+CD4+CD8-) cells. Thus, while 
the ratio of mature CD4’ to mature CD8+ cells was de- 
creased at 2-3 wpi (Figure 5B), the relative percentage 
of intrathymic CD3CD4+CD8- progenitor cells actually in- 
creased (Figure 5A). As determined by production of cell- 
associated HIV-1 p24 gag protein (data not shown), all 
three virus isolates showed similar replication rates in 
SCID-hu ThylLiv. 
To test whether the intrathymic progenitor cells were di- 
rectly infected by HIV-l, CD3CD4+CD8- and CD3+CD4+- 
CD8- populationswere isolated to>95% purity by acombi- 
nation of magnetic bead depletion of CD8+ cells and 
multiparameter flow cytometry (Figure 6A) and analyzed 
with the semiquantitative DNA PCR assay (Figure 6B). At 
3 wpi with NL4-3, viral DNA was detected in about 50% 
Figure 4. Analysis of the lntrathymic Progenitor 
Cells after HIV-1 Infection in SCID-hu ThylLiv 
Three-color flow cytometry analyses of intra- 
thymic T progenitor cells in mock-infected or 
HIV-1 (NL4-3 or EW)-infected SCID-hu thymo- 
cytes (3 wpi). The dot plots (top) show surface 
staining of CD4 and CD5 of total thymocytes. 
The histograms (bottom) show CD3 surface 
staining of the CDCCDS thymocytes. The per- 
centage of CD3-CDQCDB- cells among total 
CD4+CDB- cells is indicated. 
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Figure 5. Kinetics of HIV-1 Infection in SCID-hu Thy/Liv 
(A) Representation of CD3CD4+CD8- intrathymic T progenitor cells 
as a function of time postinfection with HIV-l isolates NL4-3, EW, or 
JD. At various times after infection, the percentage of CD3-CD4+CD8- 
cells among total CD4’CD8- cells (relative %CD3-CD4+CD8-) was de- 
termined as in Figure 4A. The number of SCID-hu Thy/Liv animals 
analyzed at each timepoint is indicated, with SEM depicted as bars. 
89NC, 89 SCID-hu Thy/Liv mice mock-infected or uninfected. ‘26 indi- 
cates combined timepoints (0.51, and 1.5 wpi) in one experiment (six 
animals at each timepoint) infected with NL4-3. All thymus grafts from 
that experiment, including negative controls (6 of the 69NC), showed 
low levels of progenitor cells, ranging between 0.0% and 8.5%. The 
remaining eight SCID-hu mice analyzed at 1 wpi with NL4-3 were from 
two independent experiments and all showed normal (NC) levels of 
the progenitor cells. Overall, 15 or more donor tissues were used to 
construct SCID-hu Thy/Liv mice shown in these experiments, and no 
significant donor variation was observed. 
(6) Representation of mature CD4+ and CD8+ T cells as a function of 
time postinfection. Mature CD4+ T cells and CD8’ T cells from the 
animals shown in Figure 5A were analyzed as CD3+CD4+CDB-I 
CD8+CD4- ratios. 
of CD3-CD4+CD8- cells but in only 10% of the CD3+CD4+- 
CD8- cells or of total thymocytes (Figure 8B; Table 1). At 
3 wpi with EW, the relative proportion was reversed: HIV-1 
DNA was detected in about 5%-10% of CD3CD4+CD8- 
cells and in about 25%-50% of CD3’CD4+CD8- cells. 
Preferential infection of the progenitor cell population by 
NL4-3 may account for the difference in progenitor cell 
representation after HIV-1 infection. Alternatively, infec- 
tion of progenitor cells by NL4-3 or EW may have different 
consequences, i.e. induction of apoptosis after NL4-3 in- 
fection versus survival after EW infection. 
To determine whether HIV-1 infection of the progenitor 
cells resulted in apoptosis, an in situ assay utilizing termi- 
nal deoxynucleotidyl transferase was performed (Figure 
7). Whereas about 50% of purified intrathymic progenitor 
cells from NL4-3-infected thymus grafts were TdT+, pro- 
genitor cells isolated from EW-infected mice showed lower 
percentages of apoptotic cells (about l-2%) at 3 wpi. At 
later times after infection (4-5 weeks), the difference be- 
tween the isolates was less pronounced, with EW infection 
also inducing apoptosis in both mature and progenitor 
CD4+ cells (Table 1). 
There is general consensus that the immunopathology of 
HIV-1 disease is associated with cytopathic effects on 
CD4+ T and myeloid cells. Yet, an enigma of the disease 
process is that so few cells in the peripheral circulation 
are productively infected by HIV-1 (Harper et al., 1986; 
Schnittman et al., 1989). How can this virus be the major 
mediator of T cell destruction (and, hence, immunosup- 
pression) in the absence of a correspondingly large virus 
load? In part, this anomaly has been addressed by recent 
experiments that quantitate viral load more precisely. 
Thus, using sensitive PM-based or flow cytometric 
assays, or both, higher viral loads have been documented 
both in the peripheral circulation (Patterson et al., 1993; 
Piatak et al., 1993) and within the parenchyma of biopsied 
lymph nodes (Embretson et al., 1993; Pantaleo et al., 
1993), even during clinically latent stages of infection. The 
experiments in this report raise an additional explanation: 
HIV-1 may directly or indirectly eliminate developing T 
cells before they even reach the peripheral circulation. 
First, we observe that HIV-1 induces apoptotic cell death 
in multiple populations of thymocytes in vivo, including 
the immature CD4+CD8+ cortical population and the more 
mature CD4+CD8- medullary population. As determined 
by a semiquantitative PCR assay for the proviral genome 
and a flow cytometric assay for the presence of DNA 
breaks (consistent with apoptosis), most dying cells show 
no evidence of HIV-1 infection. Instead, the virus appears 
indirectly to facilitate apoptotic pathways within these un- 
infected bystander cells. 
Second, we provide direct experimental evidence for 
the hypothesis (Schnittman et al., 1990; Valentin et al., 
1994) that intrathymic progenitor cells with a CD3-CD4+- 
CD6- phenotype can be infected by HIV-l. In the case of 
some HIV-1 isolates (e.g., NL43), a high proportion of 
cells in this subpopulation are not only infected but in- 
duced to die of apoptosis. These rapidly dividing cells give 
rise to the CD4+CD8+ cortical population and their more 
mature progeny (Galy et al., 1993; Kraft et al., 1993). Their 
demise, by direct or indirect means, would efficiently sup- 
press thymopoiesis. Assuming that mature T cells in the 
peripheral circulation are being turned over at a finite rate, 
this in turn would reduce the pool of peripheral CD4+ T 
cells. 
Finally, different HIV-1 isolates do not share equivalent 
tendencies to suppress thymopoiesis in vivo. Previous 
studies have shown that thymocyte depletion occurs at 
a faster pace with rapidly replicating syncytiuminducing 
isolates of HIV-1 than with slowly replicating nonsyncy- 
tium-inducing isolates (Kaneshima et al., 1994). The cur- 
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TdT-In Situ Analysis of Purified lntrrthymic Progenitor Cells 
Mock 
EW 
(3 *pi) 
Figure 7. Analysis of Apoptosis in the Purified lntrathymic Progenitor 
Populations after HIV-1 Infection 
Progenitor cells purified from mock-infected (middle), NLC5infected 
(top), or EW-infected (bottom) SCID-hu Thy/Liv are shown. The red 
cells represent apoptotic cells labeled by TdT and biotin-dUTP. 
dent upon multiple interacting variables, including intrinsic 
replication rates, viral tropism, and the relative contribu- 
tion of the destroyed target cell to generation of the total 
thymic mass. In this scenario, the most pathogenic iso- 
lates would be expected to be those that rapidly replicate 
within and result in the destruction of intrathymic T progen- 
itor cells as well as the mature CD4’ cells. 
The Relationship Between Pathogenesis 
in SCID-hu Mice and Humans 
The ThylLiv organ of the SCID-hu mouse has served pre- 
viously as a useful model for the analysis of normal thymo- 
cyte differentiation (Kraft et al., 1993; Krowka et al., 1991; 
McCune et al., 1988; Vandekerckhove et al., 1992; Waker 
et al., 1992). As judged by the parameters of viral replica- 
tion, tropism, cytopathic effects, and in vivo antiviral ef- 
fects, it also appears to reproduce faithfully the expected 
attributes of HIV-1 infection in vivo (Aldrovandi et al., 1993; 
Bonyhadi et al., 1993; Jamieson et al., 1994; Kaneshima 
et al., 1994; McCune et al., 1990; Namikawa et al., 1988; 
Stanley et al., 1993). Given these observations, the effects 
of HIV-1 infection of thymocyte differentiation in this model 
may also be reflective of those that occur in humans. Most 
appropriately, they may be relevant to the pathophysiology 
of HIV-1 infection in neonates, in whom a functioning thy- 
mus is present at the time of infection. Studies of such 
patients have revealed that the thymus can be infected 
Figure 8. Model of HIV-l-Mediated CD4+ T Cell Depletion 
(A) T cell homeostasis. Natural losses (open cross) of CD4+ T cells 
are replenished from progenitor cell populations (both in the bone 
marrow and in the thymus), which in turn are maintained by self- 
renewal, by differentiation of earlier progenitors, or by both. 
(6) HIV-1 may affect multiple steps of T cell maturation to result in 
CD4+ T cell depletion. Cell death induction may be direct (cytopathic 
infection) or indirect (mediated by viral proteins, induction of cytotoxic 
agents, or destruction of the microenvironments). 
(C) Distinct HIV-1 isolates may show differential effects on progenitor 
and mature T cells. 
with HIV-1 and that infection is associated with thymocyte 
depletion (Rosenzweig et al., 1993; Schuurman et al., 
1989; Seemayer et al., 1984). Similar observations have 
been made in SIV-infected rhesus macaques (Baskin et 
al., 1991) and in FIV-infected cats (Beebe et al., 1994). 
Although these observations are consistent with those 
made in the SCID-hu mouse, further studies will be neces- 
sary to demonstrate that the mechanisms of cytopathicity 
observed in the SCID-hu ThylLiv are operative in pediatric 
cases of HIV-1 disease. It will also be important to deter- 
mine whether the thymus is functional under physiologic, 
pathophysiologic, or both, conditions in the adult. Such 
studies, though logistically difficult, may now be guided 
by hypotheses obtained from the HIV-l-infected SCID-hu 
Thy/Liv organ. 
HIV-l-induced Changes in T Cell Homeostasls 
The immunopathogenesisof HIV-1 disease is usuallystud- 
ied in the context of changes in the peripheral blood T cell 
compartment of infected adults. The current studies focus 
attention on an important dynamic that is otherwise diffi- 
cult to analyze: the kinetics and physiology of T cell turn- 
over in vivo. Since it is not possible to enumerate and to 
localize spatially the total body CD4’ T cell population, it 
is correspondingly difficult to discriminate relative changes 
in numbers. In the peripheral blood, for example, a drop 
in CD4+ T cells could be secondary to increased destruc- 
tion, to decreased production, and/or to movement to ex- 
travascular spaces. Likewise, observations made in one 
or several biopsied lymph nodes (Embretson et al., 1993; 
Fauci, 1993; Pantaleo et al., 1993) may not necessarily 
be representative of events that occur in other peripheral 
lymphoid organs. 
We propose a model to explain HIV-induced CD4+ T cell 
loss in the context of normal T cell loss and replenishment 
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A 
1. CDB-Bead D&&B 2. 
Total CDB+-Deoleted CD4+CD3- CD4+CD3+ 
CD8 
ocvtes 
123 123 123 
123 123 123 
Figure 6. Estimation of HIV-1 Infection in Purified Human Thymocyte Subsets 
(A) lntrathymic progenitor cells (CD3-CD4+CD8-) or mature CD4+(CD3+CD4+CD8-) thymocytes were purified from SCID-hu Thy/Livgrafts. CDS-Bead 
depletion: Total, total thymocytes; CDB+-depleted, thymocytes after depletion with magnetic beads of CD8’ cells. The CD3 histograms show data 
gated for CD4+CD6- cells. FACS Purification: CD4+CD3- or CD4+CD3+, thymocytes after purification by FACS. Total cells are shown to demonstrate 
purity. 
(B) DNA prepared from total thymocytes, from the purified intrathymic progenitor cells (CD3-CD4+), or from mature CD3+CD4+ thymocytes was 
analyzed by the semiquantitative PCR assay to estimate the percentage of cells infected by HIV-l. DNA from 100 cells was used in all PCR 
reactions. Lanes 1, undiluted sample cells; lanes 2, 10 x diluted cells; lanes 3: 100x diluted cells. Infection by NL4-3 (top) or EW (bottom) was 
terminated at 3 wpi. 
rent studies suggest that differences in kinetics of thymo- suits in rapid depletion of this population, whereas infec- 
cyte depletion may also reside in the relative tropism of tion with HIV-1 isolates EW and JD leads first to depletion 
HIV-1 isolates for the intrathymic (CD3CD4+CD8-) T pro- of more mature CD4+ cells. The ability of given HIV-l iso- 
genitor cell population. NL4-3 infection, for example, re- lates to abrogate thymopoieis in vivo may thus be depen- 
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pathways (Figure 8). In normal human peripheral blood, 
the CD4’ T cell count should be maintained at a relatively 
constant level (Adleman and Wofsy, 1993; Atkinson et al., 
1982). Natural losses of CD4+ T cells must be compen- 
sated by maturation of progenitor cells from bone marrow 
as well as from thymus. Infection of progenitor cells by 
HIV-1 may lead to the following: generation of a reservoir 
to transmit the HIV-1 genome to progeny cells (e.g., 
CD8+CD4- thymocytes in SCID-hu ThylLiv also harbor the 
HIV-1 genome; data not shown); destruction of a popula- 
tion that could provide progeny cells (reduction of progeni- 
tor cell pool); and introduction of a maturational block upon 
normal thymocyte differentiation processes. Mature CD4+ 
T cells may also be infected or induced to die, or both, 
by HIV-l. Induction of cell death, either by direct or indirect 
mechanisms, may occur through an abnormal pathway 
(closed cross) or via pathways normally engaged during 
thymocyte differentiation (open cross). 
Based on the effects of HIV-1 infection at different steps 
of CD4’ T cells maturation and function, it may also be 
possible to classify subtypes of HIV-l. For example, NL4-3 
may be defined as a subtype that preferentially targets 
CD4’ progenitor cells and EW or JD as subtypes that pref- 
erentially target mature CD4+ thymocytes. Such distinc- 
tions may be especially important to consider at earlier 
stages of infection, when a restricted array of viral geno- 
types is transmitted (Delwart et al., 1994; Zhu et al., 1993). 
In this context, it is interesting to note that HIV-1 infections 
can occasionally result in isolated cytopenias (Calenda 
and Chermann, 1992; Murphy et al., 1987; Najean and 
Rain, 1994; Spivak et al., 1983), consistent with the possi- 
bility that they were initiated by virus subtypes specific for 
hematopoietic progenitor cells. 
neighboring cells, even in the presence of antiviral agents 
(e.g., nucleoside analogs), which would otherwise sup- 
press further viral spread. Finally, it is possible that cells 
that are directly infected by HIV-1 may be induced into 
apoptotic death by mechanisms that are similar to those 
at play in indirect killing. It may accordingly be important 
to administer combinations of drugs that serve both to 
suppressviral replication and to prevent the ability of HIV-1 
to induce apoptosis either directly or indirectly. 
Experimental Procedures 
SCID-hu ThylLiv Mice 
Animal transplantation procedures have been described elsewhere 
(Namikawa et al., 1990). 
HIV-1 Viral Stock Preparatlons 
NL4-3 (Adachi et al., 1966) virus stocks were prepared by transfecting 
HIV-1 proviral DNA into phyiohemagglutinin (PHA)-activated periph- 
eral blood mononuclear cells (PBMC) cultured in the presence of in- 
terleukin-2 (IL-2) (Bonyhadi et al., 1993). Primary isolates EW and JD 
were prepared by cocultivation of peripheral blood mononuclear cells 
from HIV-1 seropositive patients with PHA-activated PBMC in the pres- 
ence of IL-2 (Bonyhadi et al., 1993). Virus-containing supernatants 
were harvested after a limited number (n < 4) of passages on PBMC 
in vitro and standardized with respect to levels of p24 and TCIDsdml. 
Stocks with HIV-1 titers of 4 x 1 O’TClDsdml (on PHA-activated PBMC) 
were used in the experiments. 
HIV-1 Infection, p24 Assays, and FACS Analyses 
HIV-1 infection of SCID-hu mice was performed as described (Bony- 
hadi et al., 1993). SCID-hu Thy/Liv mice (4-6 months after transplanta- 
tion) were infected with supernatant collected from PHA-activated 
PBMC containing no HIV-1 (mock) or 4 x lo4 TClD&ml of HIV-I. 
Of 2000 TCIDa, 50 ~1 were injected into each thymus graft. Human 
thymocytes were harvested from the grafts at the indicated times after 
infection, and p24 levels from IO6 thymocytes were determined by an 
ELISA assay (DuPont). Thymocyies were stained and analyzed by flow 
cytometry as previously described (Bonyhadi et al., 1993). 
The Indirect Cytopathic Effects of HIV-1 
HIV-l-induced apoptosis has been observed previously in 
vitro after infection of T cells (Laurent et al., 1991; Terai 
et al., 1991) or after exposure of uninfected CD4’ T cells 
(and CD4’” hematopoietic progenitor cells) to viral compo- 
nents such as gp120 (Banda et al., 1992; Finkel and 
Banda, 1994; Laurent et al., 1993). The present data docu- 
ment the importance of this mechanism of viral cytopathi- 
city within an in vivo setting. In addition to suppressing 
thymocyte maturation by destruction of progenitor cells, 
HIV-1 induces apoptosis indirectly within uninfected prog- 
eny that have had the chance to differentiate. 
Several inferences follow immediately from this obser- 
vation. First, it would appear as though HIV-1 has evolved 
to facilitate a normal physiologic process: namely, the 
massive levels of apoptosis that occur during negative 
selection of developing thymocytes. The pathophysiologic 
consequences of this adaptation could include both T cell 
depletion and the induction of intrathymic tolerance 
against HIV-1 (McCune, 1991), thereby abrogating active 
immune responses against HIV-1 in the periphery. Se& 
ond, although it is clear that HIV-l-mediated thymocyte 
depletion requires active viral replication after de novo 
infection, it is not evident that suppression of an ongoing 
infection will prevent indirect killing. Cells that are already 
induction of Apoptosls in Mouse Thymocytes 
with Dexamethasone 
BALB/c mice (4-6 weeks old) were treated with dexamethasone by 
intraperitoneal injection (0.1 ml, 5 mg/ml in phosphate-buffered saline). 
Thymocytes were isolated and analyzed 12 hr later. DNA ladder forma- 
tion was assayed, as described (Gorczyca et al., 1993), to monitor the 
induction of apoptosis. 
TdT-FACS 
This procedure was adapted from Gorczyca et al. (1993). In brief, IO6 
cells were stained with antibodies and fixed in 1% paraformaldehyde 
for 1 hr, followed by treatment in cold (-20°C) 75% EtOH for 1 hr. 
The TdT reaction was carried out essentially as recommended by the 
manufacturer (Boehringer Mannheim Biochemicals) in the presence 
of biotin-dUTP. Avidin-conjugated fluorescein isothiocynate (Caltag) 
was used to detect the biotin-dUTP incorporated onto DNA ends. 
FACS analyses were performed on FACScan or FACStar and with the 
LYSIS II program (Becton-Dickinson lmmunocytometry System). 
TdT In Situ 
Purified thymic progenitor or mature CD4+ cells (about 5000) were 
pelleted onto glass slides using a cytospin. Detection of apoptotic cells 
was carried out essentially as described above. In brief, the cells on 
slides were air-dried, washed in phosphate-buffered saline for 10 min, 
rinsed in dH,O, and permeablized in 75% EtOH for 1 hr. They were 
then rinsed three times in distilled water. The TdT reaction was per- 
formed as in the TdT-FACS assay. The reaction was terminated with 
a phosphate-buffered saline wash and incubated with stop buffer (300 
mfvl NaCI, 30 mM Na-citrate, 0.1% Triton X-100 in phosphate-buffered 
saline) containing streptavidin-conjugated alkaline phosphatase (Boeh- 
infected may still be able to deliver an apoptotic signal to ringer Mannheim Biochemicals). After incubation at room temperature 
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for 1 hr, alkaline phosphatase was detected with a calorimetric assay 
as described (McCune et al., 1990). TdT-labeled cells were counted in 
fields containing 500-1000 cells to estimate percentages of apoptotic 
cells. 
Semlquantitatlve DNA-PM Analysis 
Cell lysis and DNA preparation were carried out essentially as de- 
scribed (McCune et al., 1990). In brief, 2000 cells were lysed in 200 
ul of 1 x PCR buffer (50 mM KCI, 20 mM Tris-HCI (pH 9.01, 1.5 mM 
MgCI,, 0.5% Tween 20, 0.5% NP40) with 100 @ml of proteinase K 
at 60°C for >2 hr. Proteinase K was inactivated at 95OC for 15 min. 
DNA from 100 cells (10 ul) was then directly used in PCR reactions 
with HIV-1 primers (SK145 and SK431) and human 6-globin primers 
(SC1 and SC2) in 100 pl total volume. When indicated, dilutions of 
the DNA samples were performed with DNA prepared with normal 
human thymocytes at the same concentration (Le., 10 cells/PI). Thus, 
DNA from 100 cells was used in all PCR reactions. The PCR reactions 
were carried out for 40 cycles (McCune et al., 1990). PCR products 
(10 ul) were analyzed on a 3% agarose (2% NuSieve, 1% Seakem) 
gel containing 5 nglml of EtBr. Human 6-globin gene (266 bp) was 
amplified as a positive control for human cells. The PCR product for 
HIV-1 DNA is from the HIV-l gag region (142 bp). ACHP cells were 
mixed with normal human thymocytes to prepare cell populations with 
50%, 25%, 10%. 5%, l%, or no ACH2 cells, which were used to 
prepare DNA to standardize each PCR reaction. The sensitivity of the 
assay was 1 ACH2 cell/l 00 total cells and a semiquantitative response 
was observed between 1-l 0 ACHP cells. DNA samples prepared from 
the 50%, 25%. 1 O%, or 5% of ACH2/normal cell mixtures were diluted 
(10 x or 100 x) with DNA prepared with normal human thymocytes at 
thesame concentration (lOcells/ul). DNAsamplesfrom HIV-1 infected 
thymocytes were also diluted 10 x or 100 x and analyzed as above. 
ACH2 titration standards (Figure 2A) were included in each PCR analy- 
sis. Sample DNA was compared directly with DNA solutions containing 
501, 25%, lo%, 5%, or 1% of ACHP cells. Each experiment was 
repeated at least twice to derive an estimation of percentages of HIV-1 
infection. 
Purlficetlon of the lntrathymlc Progenltor Cells 
As previously described (Kraftet al.. 1993) CDSCD4+CD6-progenitor 
cells were purified by first depleting CD8+ cells with magnetic beads 
(anti-CD&biotin and -strepavidin beads, Dynaf). The remaining (CD8-) 
cells were then labeled with anti-CD3 tricolor, antiCD4-phycoerythrin. 
anti-CD8-fluorescein isothiocyanate, and streptavidin-fluorescein 
isothiocyanate (Becton-Dickinson lmmunocytometry System). After 
fixation in 1% paraformaldehyde, CD3%D4’CD8- or CD3+CD4+CD8- 
cells were purified on a FACSTAR Plus machine (Becton-Dickinson 
lmmunocytometry System). Reanalyses of purified thymocyte subsets 
showed >95% purity. 
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